Navigation Links
MyCancerPain.org Launched as Resource for Patients with Painful Bone Metastases
Date:12/16/2008

TIRAT CARMEL, Israel, December 16 /PRNewswire/ -- InSightec Ltd. announced today that cancer patients suffering pain caused by tumors that have spread to their bones have a new online resource for information about their condition. The website, http://www.MyCancerPain.org, provides background on bone metastases, as well as detailed information about a clinical trial being conducted at eleven centers in the U.S., Canada and Israel to evaluate whether treatment with the noninvasive, ionized radiation-free ExAblate(R) Magnetic Resonance-guided Focused Ultrasound (MRgFUS) system can safely and effectively alleviate this pain.

"As modern oncology treatments have helped patients live longer with their disease, growing numbers of patients are living with the side effects of late-stage cancer, including bone pain," said Andre A. Konski, MD, MBA, MA, Director of Radiation Oncology Clinical Research and Chief Medical Officer at Fox Chase Cancer Center. "As physicians, our goal is not only to treat disease, but to help improve the quality of our patients' lives. We look forward to enrolling additional patients into this study in hopes of showing that this treatment may provide safe and effective pain relief for this condition. We encourage patients with bone metastases and their families to gather information on palliative treatments, including clinical trials such as this one, and discuss their options with their physicians."

Bone pain is the most common source of pain in patients suffering from metastatic cancer. Almost all patients with metastatic prostate cancer have skeletal metastases and 90% of patients with progressive breast cancer develop these painful and debilitating lesions.

Current pain treatments consist of systemic therapy (analgesics, chemotherapy, hormonal therapy and bisphosphonates) and local treatments (radiation, surgery and more recently, Radio Frequency Ablation (RFA)).

With ExAblate(R), the physician uses the Magnetic Resonance Imaging (MRI) with registered CT images to visualize the patient's anatomy and then aims focused ultrasound waves at the tumor to relieve the pain. The MRI allows the physician to monitor and continuously adjust the treatment in real time. The patient is consciously sedated to alleviate pain and minimize motion. Due to the high acoustic absorption and low thermal conductivity of the bone cortex, it is possible to use a low level of energy and still achieve a localized heating effect that will relieve the pain while minimizing damage to adjacent tissue.

Participating sites include Brigham & Women's Hospital in Boston, Fox Chase Cancer Center in Philadelphia, Houston Methodist in Houston, Texas, SightLine Medical Center, Houston, Texas, the Lahey Clinic in Burlington, Mass., the University of California, Los Angeles Medical Center in Los Angeles, Calif., the University of California, San Diego Medical Center in San Diego, Calif., Weill Cornell Medical College in New York, University Health Network in Toronto, and Sheba Medical Center in Tel Hashomer, Israel.

Additional information on the trial, including contact information for the clinical coordinators at each of the sites, can also be viewed at the National Institutes of Health's website, http://www.clinicaltrials.gov/ct2/show/NCT00656305?term=bone+metastases+insig htec&rank=1.

(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

    Media Contact:
    Hollister Hovey
    Lazar Partners Ltd.
    hhovey@lazarpartners.com
    +1-212-867-1762


'/>"/>
SOURCE InSightec Ltd
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. National Drug Development Accelerator Launched
2. Unique New Initiative by World-Recognized Specialists in Heart Disease and Diabetes to Reduce Residual Vascular Risk Launched Today
3. Orange and Medic4all Launched the Worlds First Cellular Tele-Health Service
4. The MaxCyte STX Scalable Transfection System to be Launched at the SBS Symposium on Cell-Based Assays
5. BioInnovation Institute in Akron Launched
6. Integrated Prevention Demonstration Campaign Launched in Western Kenya to Fight HIV, Malaria and Diarrhoeal Disease
7. Informex365.com is Launched for Manufacturers in Search of Chemical Reactions Expertise
8. GANIC Pharmaceuticals Launched with Premier Pharmaceutical Industry Executives
9. Partnering for Philanthropy Conference Launched to Unite Innovative Non-profit Research Organizations with Philanthropists and Industry
10. Augusta Systems Technologies Integrated into Ciscos Newly Launched Safety and Security Platform
11. Collaborative Biosecurity Research Initiative Launched to Target Animal and Public Health Threats Nationally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are the main ... people each year. Especially those living in larger cities are affected by air pollution ... of the most pollution-affected countries globally - decided to take action. , “I knew ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive ... a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... CRUZ, Calif. , Oct. 10, 2017 ... grant from the NIH to develop RealSeq®-SC (Single Cell), ... kit for profiling small RNAs (including microRNAs) from single ... Analysis Program highlights the need to accelerate development of ... "New techniques for measuring ...
(Date:10/9/2017)... FL (PRWEB) , ... October 09, 2017 , ... The ... scheduled to broadcast first quarter 2018. American Farmer airs Tuesdays at 8:30aET on RFD-TV. ... industry is faced with the challenge of how to continue to feed a growing ...
Breaking Biology Technology:
(Date:4/11/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 30.37% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
(Date:4/11/2017)... 2017 NXT-ID, Inc. (NASDAQ:   NXTD ... the appointment of independent Directors Mr. Robin D. Richards ... of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief ... to their guidance and benefiting from their considerable expertise as ...
(Date:4/5/2017)...  The Allen Institute for Cell Science today announces ... portal and dynamic digital window into the human cell. ... application of deep learning to create predictive models of ... a growing suite of powerful tools. The Allen Cell ... publicly available resources created and shared by the Allen ...
Breaking Biology News(10 mins):